US Bancorp’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-297
| Closed | -$1K | – | 3912 |
|
|
2019
Q4 | $1K | Buy |
+297
| New | +$1.4K | ﹤0.01% | 3630 |
|
|
2019
Q3 | – | Sell |
-212
| Closed | -$1K | – | 3738 |
|
|
2019
Q2 | $1K | Sell |
212
-688
| -76% | -$3.66K | ﹤0.01% | 3592 |
|
|
2019
Q1 | $5K | Buy |
900
+515
| +134% | +$5.32K | ﹤0.01% | 3262 |
|
|
2018
Q4 | $5K | Sell |
385
-2,470
| -87% | -$41.6K | ﹤0.01% | 3239 |
|
|
2018
Q3 | $55K | Sell |
2,855
-544
| -16% | -$11.6K | ﹤0.01% | 2515 |
|
|
2018
Q2 | $87K | Sell |
3,399
-8,184
| -71% | -$191K | ﹤0.01% | 2316 |
|
|
2018
Q1 | $233K | Sell |
11,583
-6,475
| -36% | -$151K | ﹤0.01% | 1794 |
|
|
2017
Q4 | $363K | Sell |
18,058
-806
| -4% | -$15.9K | ﹤0.01% | 1581 |
|
|
2017
Q3 | $390K | Buy |
18,864
+1,995
| +12% | +$33.7K | ﹤0.01% | 1536 |
|
|
2017
Q2 | $250K | Sell |
16,869
-637
| -4% | -$10.6K | ﹤0.01% | 1732 |
|
|
2017
Q1 | $278K | Sell |
17,506
-365
| -2% | -$5.26K | ﹤0.01% | 1653 |
|
|
2016
Q4 | $225K | Buy |
17,871
+7,075
| +66% | +$132K | ﹤0.01% | 1748 |
|
|
2016
Q3 | $301K | Buy |
10,796
+3,488
| +48% | +$117K | ﹤0.01% | 1565 |
|
|
2016
Q2 | $257K | Buy |
7,308
+2,185
| +43% | +$68.7K | ﹤0.01% | 1607 |
|
|
2016
Q1 | $140K | Buy |
5,123
+795
| +18% | +$23.4K | ﹤0.01% | 1843 |
|
|
2015
Q4 | $148K | Buy |
+4,328
| New | +$135K | ﹤0.01% | 1845 |
|
Other funds holding DPLO
US Bancorp's DPLO Position: Q1 2020 in Review
US Bancorp sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 297 shares — an estimated $1K sold.
US Bancorp first reported a position in DPLO in Q4 2015 and held it in 16 quarters. The position peaked at $390K in Q3 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- US Bancorp reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- US Bancorp sold 297 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1K.
- US Bancorp first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 16 quarters.
- US Bancorp's DIPLOMAT PHARMACY, INC. position peaked at $390K in Q3 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on US Bancorp's 13F filing for Q1 2020, filed 13 May 2020.